for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

West Pharmaceutical Services Inc.

WST.N

Latest Trade

408.72USD

Change

3.91(+0.97%)

Volume

82,506

Today's Range

402.95

 - 

408.84

52 Week Range

254.15

 - 

475.03

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
404.81
Open
402.95
Volume
82,506
3M AVG Volume
7.03
Today's High
408.84
Today's Low
402.95
52 Week High
475.03
52 Week Low
254.15
Shares Out (MIL)
73.98
Market Cap (MIL)
29,947.47
Forward P/E
49.30
Dividend (Yield %)
0.17

Next Event

Q3 2021 West Pharmaceutical Services Inc Earnings Release

Latest Developments

More

West Announces First-Quarter 2021 Results

West Announces Q4 Adjusted Earnings Per Share $1.34

West Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program And Participation In Upcoming Investor Conference

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Industry

Medical Equipment & Supplies

Contact Info

530 HERMAN O WEST DR

EXTON, PA

19341-1147

United States

+1.610.5942900

https://www.westpharma.com/

Executive Leadership

Patrick J. Zenner

Independent Chairman of the Board

Eric Mark Green

President, Chief Executive Officer, Director

Bernard John Birkett

Chief Financial Officer, Senior Vice President

David A. Montecalvo

Senior Vice President, Chief Operating and Supply Chain Officer

Annette F. Favorite

Chief Human Resource Officer, Senior Vice President

Key Stats

2.00 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

1.7K

2019

1.8K

2020

2.1K

2021(E)

2.8K
EPS (USD)

2018

2.810

2019

3.240

2020

4.760

2021(E)

8.212
Price To Earnings (TTM)
59.16
Price To Sales (TTM)
11.87
Price To Book (MRQ)
14.74
Price To Cash Flow (TTM)
49.01
Total Debt To Equity (MRQ)
12.50
LT Debt To Equity (MRQ)
12.39
Return on Investment (TTM)
22.16
Return on Equity (TTM)
18.63

Latest News

Latest News

BRIEF-West Pharmaceutical Services To Join S&P 500 Index

* WEST PHARMACEUTICAL SERVICES, INC. TO JOIN S&P 500 INDEX Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-West Pharmaceutical Services Says Q1 Adjusted Earnings Per Share $1.01

* Q1 EARNINGS PER SHARE ESTIMATE $0.82 -- REFINITIV IBES DATA

BRIEF-West Elects New Director, Robert Friel, To Board

* WEST PHARMACEUTICAL SERVICES - BOARD HAS ELECTED ROBERT FRIEL AS ITS NEWEST MEMBER

BRIEF-West Announces Q4 Earnings Per Share $0.84

* Q4 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up